SCHEMBL79003

SCHEMBL79003

C=CC(C)(C)C(=O)OCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.43
CYP4F2 P78329 3/20 0.41
CYP4A11 Q02928 3/20 0.41
ALDH1A1 P00352 3/20 0.40
MMP8 P22894 1/20 0.39
LMNA P02545 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
THRB P10828 1/20 0.37
ALOX15 P16050 1/20 0.37
MGAM O43451 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
SOAT1 P35610 1/20 0.37
ABCB11 O95342 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28868019 0.87 GAA (0.38) PKMCYP4F2CYP4A11ALDH1A1MMP8
SCHEMBL9449270 0.86 CYP4F2 (0.48) PKMCYP4F2CYP4A11ALDH1A1MMP8
SCHEMBL9449272 0.86 CYP4F2 (0.48) PKMCYP4F2CYP4A11ALDH1A1MMP8
SCHEMBL27773595 0.83 PKM (0.41) PKMCYP4F2CYP4A11ALDH1A1MMP8
SCHEMBL2915795 0.82 PKM (0.43) PKMCYP4F2CYP4A11ALDH1A1MMP8
SCHEMBL17199337 0.81 CYP4F2 (0.42) PKMCYP4F2CYP4A11ALDH1A1MMP8
SCHEMBL18421753 0.81 CYP4F2 (0.42) PKMCYP4F2CYP4A11ALDH1A1MMP8
SCHEMBL3135439 0.80 PKM (0.42) PKMCYP4F2CYP4A11ALDH1A1MMP8
SCHEMBL1164357 0.80 ALDH1A1 (0.32) ALDH1A1CYP3A4
SCHEMBL1564215 0.80 TSHR (0.40) PKMALDH1A1HSD17B10KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228680-A1 METHOD FOR PREPARING POLYMER, AND OBTAINED POLYMER CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2024-07-11 US disclosed
EP-4332135-A1 METHOD FOR PREPARING POLYMER, AND OBTAINED POLYMER CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2024-03-06 EP disclosed
CN-115246902-B Method for preparing copolymer, copolymer and application 中国石油化工股份有限公司 2023-08-15 CN disclosed
CN-115246901-B Preparation method of olefin-unsaturated carboxylic ester copolymer and copolymer 中国石油化工股份有限公司 2023-08-15 CN disclosed
CN-115246900-B Polymer preparation method and polymer 中国石油化工股份有限公司 2023-08-15 CN disclosed
CN-115260356-B Method for preparing olefin-unsaturated carboxylic ester copolymer, olefin-unsaturated carboxylic ester copolymer and application 中国石油化工股份有限公司 2023-07-21 CN disclosed
CN-116284527-A Ultrahigh molecular weight polyolefin and preparation method thereof 中国石油化工股份有限公司 2023-06-23 CN disclosed
CN-116217759-A Coordination precipitation polymerization method for olefin polymerization and obtained polyolefin 中国石油化工股份有限公司 2023-06-06 CN disclosed
CN-116199806-A Coordination precipitation polymerization method for olefin polymerization and obtained polyolefin 中国石油化工股份有限公司 2023-06-02 CN disclosed
WO-2022227933-A1 METHOD FOR PREPARING POLYMER, AND OBTAINED POLYMER 中国石油化工股份有限公司 2022-11-03 WO disclosed
US-7919497-B2 Analogs of dehydrophenylahistins and their therapeutic use NEREUS PHARMACEUTICALS, INC. (US) 2011-04-05 US disclosed
US-7919497-B2 Analogs of dehydrophenylahistins and their therapeutic use NEREUS PHARMACEUTICALS, INC. (US) 2011-04-05 US disclosed
US-7674903-B2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof NEREUS PHARMACEUTICALS, INC. (US) 2010-03-09 US disclosed
US-7674903-B2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof NEREUS PHARMACEUTICALS, INC. (US) 2010-03-09 US disclosed
WO-2010017132-A1 CERTAIN KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF CHDI, INC. (US) 2010-02-11 WO disclosed
US-20080221122-A1 ANALOGS OF DEHYDROPHENYLAHISTINS AND THEIR THEAPEUTIC USE BEYONDSPRING PHARMACEUTICALS, INC. 2008-09-11 US disclosed
US-20080221122-A1 ANALOGS OF DEHYDROPHENYLAHISTINS AND THEIR THEAPEUTIC USE BEYONDSPRING PHARMACEUTICALS, INC. 2008-09-11 US disclosed
US-20070078138-A1 Analogs of dehydrophenylahistins and their therapeutic use BEYONDSPRING PHARMACEUTICALS, INC. 2007-04-05 US disclosed
US-20070078138-A1 Analogs of dehydrophenylahistins and their therapeutic use BEYONDSPRING PHARMACEUTICALS, INC. 2007-04-05 US disclosed
US-4944795-A HERBICIDES ELI LILLY AND COMPANY (US) 1990-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078138-A1 Analogs of dehydrophenylahistins and their therapeutic use MKI67, HPGDS, HCCS PKM 3482/4885CYP4F2 1513/4885CYP4A11 815/4885
US-20080221122-A1 ANALOGS OF DEHYDROPHENYLAHISTINS AND THEIR THEAPEUTIC USE HPGDS, DHPS, HCCS PKM 3105/4885CYP4F2 1556/4885CYP4A11 434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.